Also agree with your sentiments john12, however the short / med term value in this stock is clearly FDA approval (which I think is likely) and not commercialisation of ilumen. In the longer term (say 12-24m) post FDA there will be some upside to revenue growth but SP is all about FDA!!
Also agree with your sentiments john12, however the short / med...
-
- There are more pages in this discussion • 442 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $7.769M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $9.317K | 548.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 432500 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 425475 | 1 |
View Market Depth
| Last trade - 13.54pm 28/10/2024 (20 minute delay) ? |
| TRI (ASX) Chart |